The Ludwig Institute for Cancer Research Ltd (LICR)is a global non profit committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

LICR believes that clinical research in cancer cannot be undertaken as simply product development, but rather requires a systematic, academic approach to develop rational therapeutic strategies in the only setting that really counts—the cancer patient. LICR is one of few academic organizations that plans, conducts, administers and sponsors its own clinical trials as part of its technology development process. More »